Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Irradiated Human Fibroblasts as a Substitute Feeder Layer to Irradiated Mouse 3T3 for the Culture of Human Corneal Epithelial Cells: Impact on the Stability of the Transcription Factors Sp1 and NFI. | Int J Mol Sci | 2019 | 31847118 | PubTator, text mining | PubMed |
| Genetic Dissection of Femoral and Tibial Microarchitecture. | JBMR Plus | 2019 | 31844829 | PubTator, text mining | PubMed |
| Oral administration of N-acetyl cysteine prevents osteoarthritis development and progression in a rat model. | Sci Rep | 2019 | 31822750 | PubTator, text mining | PubMed |
| Icariin Alleviates IL-1β-Induced Matrix Degradation By Activating The Nrf2/ARE Pathway In Human Chondrocytes. | Drug Des Devel Ther | 2019 | 31819369 | PubTator, text mining | PubMed |
| Osteoarthritis and Cartilage Regeneration: Focus on Pathophysiology and Molecular Mechanisms. | Int J Mol Sci | 2019 | 31817613 | PubTator, text mining | PubMed |
| Long non-coding XIST raises methylation of TIMP-3 promoter to regulate collagen degradation in osteoarthritic chondrocytes after tibial plateau fracture. | Arthritis Res Ther | 2019 | 31815654 | PubTator, text mining | PubMed |
| Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases. | Front Oncol | 2019 | 31803630 | PubTator, text mining | PubMed |
| Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism. | Sci Rep | 2019 | 31757977 | PubTator, text mining | PubMed |
| Dexamethasone: chondroprotective corticosteroid or catabolic killer? | Eur Cell Mater | 2019 | 31755076 | PubTator, text mining | PubMed |
| lncRNAs: function and mechanism in cartilage development, degeneration, and regeneration. | Stem Cell Res Ther | 2019 | 31753016 | PubTator, text mining | PubMed |
| APOE-knockout in rabbits causes loss of cells in nucleus pulposus and enhances the levels of inflammatory catabolic cytokines damaging the intervertebral disc matrix. | PLoS One | 2019 | 31751427 | PubTator, text mining | PubMed |
| A multi-chamber tissue culture device for load-dependent parallel evaluation of tendon explants. | BMC Musculoskelet Disord | 2019 | 31739778 | PubTator, text mining | PubMed |
| Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture. | Arthritis Res Ther | 2019 | 31722745 | PubTator, text mining | PubMed |
| Collagen turnover profiles in chronic kidney disease. | Sci Rep | 2019 | 31690732 | PubTator, text mining | PubMed |
| Melanoma-Derived Exosomes Induce PD-1 Overexpression and Tumor Progression via Mesenchymal Stem Cell Oncogenic Reprogramming. | Front Immunol | 2019 | 31681332 | PubTator, text mining | PubMed |
| Agonism of GPR39 displays protective effects against advanced glycation end-product (AGE)-induced degradation of extracellular matrix in human SW1353 cells. | Arch Biochem Biophys | 2019 | 31678046 | PubTator, text mining | PubMed |
| Single-nucleotide polymorphisms in the coding region of a disintegrin and metalloproteinase with thrombospondin motifs 4 and hepatocellular carcinoma: A retrospective case-control study. | Cancer Med | 2019 | 31663692 | PubTator, text mining | PubMed |
| Notch1-ADAM8 positive feed-back loop regulates the degradation of chondrogenic extracellular matrix and osteoarthritis progression. | Cell Commun Signal | 2019 | 31640732 | PubTator, text mining | PubMed |
| Assessment of biochemical recurrence of prostate cancer (Review). | Int J Oncol | 2019 | 31638194 | PubTator, text mining | PubMed |
| LncRNA MALAT1/MiR-145 Adjusts IL-1β-Induced Chondrocytes Viability and Cartilage Matrix Degradation by Regulating ADAMTS5 in Human Osteoarthritis. | Yonsei Med J | 2019 | 31637891 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=60